CEPHEID UK LIMITED: UK Public Sector Contracts Won & Awards
SME·Solihull·West Midlands·Main market: Various medicinal products
Companies House04422108 ↗Websitecepheid.com ↗
Procedures with an award1818 award recordsPublic authorities13named on published awardsAttributable award value£7.9mnet · on 14 of 18 award records · single-supplier, no ceilingsLast 12 months7awards · 2 in the prior 24 months · last 25 Aug 2026Contracts ending ≤18 months3end date published on 6 of 18 awardsDelivery regions11most often South West England
Where they win
18 lot-level observations (11 awarded lots, 61%, plus 7 envelope awards without lot links; pending awards included) · top CPV classes
3369 Various medicinal products5 observations · 28% · 4 lots + 1 envelope5042 Repair and maintenance services of medical and surgical equipment3 observations · 17% · lots3314 Medical consumables4 observations · 22% · 1 lots + 3 envelope3312 Recording systems and exploration devices1 observations · 6% · lots3891 Hygiene monitoring and testing equipment1 observations · 6% · lots3895 Polymerase Chain Reaction (PCR) equipment1 observations · 6% · lots3310 Medical equipments2 observations · 11% · envelope awards3300 Medical equipments, pharmaceuticals and personal care products1 observations · 6% · envelope awardsAttributable award value£7.9mSum of published VAT-exclusive values on 14 of 18 award records — only awards to this supplier alone, framework / DPS ceilings excluded; the award’s own value, else its contract’s; the five largest make 81%. Not turnover. Largest rows below.
Typical attributable award£257k medianrobust · n=14
| Largest published awards | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| NSSCOVID-19 -189 Point of Care Testing | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | — | — | £4,000,000 † |
| Cepheid Cov2/FLU/RSV/MRSA Reagents | Cambridge University Hospitals NHS Foundation Trust | 25 Aug 2026 | 1 yrs · up to 2 yrs | £816,150 ≈ £816k/yr |
| Procurement of rapid result diagnostic kits | Cambridge University Hospitals NHS Foundation Trust | 10 Sept 2025 | 1 mo | £518,000 |
| Pathology Rapid PCR testing systems,reagents & maintenance | Salisbury NHS Foundation Trust | — | 1 yrs | £516,000 † ≈ £516k/yr |
| TSDFT - COVID TEST KITS | Torbay and South Devon NHS Foundation Trust | — | — | £500,000 † |
Where they deliver
ITL1 delivery regions on the notice · 13 of 18 awarded procedures publish one · a procedure with several regions counts in each
South West England5 procedures · 38%
East of England4 procedures · 31%
Scotland4 procedures · 31%
Greater London3 procedures · 23%
Nationwide (UK)2 procedures · 15%
North East England2 procedures · 15%
North West England2 procedures · 15%
Yorkshire and the Humber2 procedures · 15%
Who they sell to
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
- Central government 56% (10 awards)
- NHS & health 33% (6 awards)
- Type not classified 11% (2 awards)
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| Cambridge University Hospitals NHS Foundation Trust | 2 | 11.1% | 2 | 25 Aug 2026 |
| Somerset NHS Foundation Trust | 2 | 11.1% | 2 | 19 Aug 2026 |
| The Newcastle Upon Tyne Hospitals NHS Foundation Trust | 2 | 11.1% | 2 | 7 Nov 2025 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 2 | 11.1% | 2 | 1 Apr 2026 |
| Salisbury NHS Foundation Trust | 2 | 11.1% | 2 | 3 Jul 2026 |
| York and Scarborough Teaching Hospital NHS Foundation Trust | 1 | 5.6% | 1 | 4 Sept 2025 |
| Scottish National Blood Transfusion Service | 1 | 5.6% | 1 | 11 Feb 2022 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 1 | 5.6% | 1 | 23 Jun 2021 |
Share = of the 18 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts ending
Published end dates only · 6 of 18 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Pathology Rapid PCR testing systems,reagents & maintenance | 14 Dec 2026 | £516,000 |
| Cepheid - GeneXpert IV - Advantage Service | 14 Dec 2026 | £12,598 |
| Maintenance of GeneXpert IV-4 module | 31 Mar 2027 | £22,222 |
Recent awards
Latest 18 of 18 award records naming this supplier
Data coverage & method
- Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
- Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
- Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
- Published value attributable to this supplier alone: £7.9m across single-supplier awards, framework / DPS ceilings excluded. Coverage is partial and the figure is not turnover, so it is not shown as a headline.
- Contract end dates: published on 6 of 18 awards; 3 end within 18 months.
- Never shown: contact details, reliability or payment scores, affiliations, predicted wins.
Identifiers consolidated into this page (7 historical Find a Tender publication identifiers)
Official notices referenced this supplier under these publication identifiers. Alias URLs are not separate pages.
Canonical page id: GB-COH:04422108